Are you passionate about helping customers with solutions leveraging the state-of-the-art AI-driven computational platform? Come join us! We are seeking a highly motivated candidate who will serve as a liaison between the VSL Technical Sales and the Client. We are looking for an exceptional candidate, who will be the Subject Matter Expert for helping customers in designing solutions that leverage our software and technical services. You will partner with Translational Sciences, Biosimulation, AI/ML, Sales, and the Business Development teams to enable customer adoption and revenue attainment for the BIOiSIM portfolio of products, and the tech-enabled services. You will also work with the Marketing team to develop white papers, blogs, reference implementations, case studies, and presentations to evangelize VSL platform and best practices for all of the services. And, most important - you will act as the steward for developing winning VSL capabilities for our customers. You will also need to be a highly engaged, positive team player and show a high degree of customer focus. The ideal candidate is a lifelong learner who is excited and willing to learn about AI/ML and the drug development process, and can succeed in an innovative, fast-paced, high-intensity startup environment.
VeriSIM Life has developed a sophisticated computational platform that leverages advanced AI and ML techniques to significantly improve drug discovery and development by greatly reducing the time and money it takes to bring a drug to market. BIOiSIM is a first-in-class 'virtual drug development engine' that offers unprecedented value for the drug development industry by narrowing down the number of drug compounds that offer anticipated value for the treatment or cure of specific illnesses or diseases. The program not only reduces the time and cost of drug discovery and development, it also greatly reduces the need for animal testing that, in the vast majority of cases, does not translate to humans (over 90% of drugs that are currently tested in animals fail to pass human clinical trials).